Abstract: Objective To investigate the clinical effect of transurethral plasma enucleation on bladder tumor and analyze its effect on accurate tumor staging. Methods A total of 100 Patients diagnosed with non-muscle-invasive bladder cancer(NMIBC) before surgery were selected from September 2016 to December 2017 , and were divided into transurethral resection of bladder tumor (TURBT) group and plasmakinetic enucleation of bladder tumors (PKEBT) group . We compared the difference between the two groups on accurate pathological staging, operation time, the rate of muscle-invasive bladder cancer (MIBC) and recurrence rate within 12 months after surgery. Results There was no statistically significant difference in operative time between the two groups (P>0.05). The MIBC detection rate of PKEBT group is higher than TURBT group (24%vs8%, P=0.029). The recurrence rates of the PKEBT group were lower than TURBT group at 3, 6, 9 and 12 months postoperatively (2.63%vs17.39%, 5.26%vs21.73%, 10.52%vs28.26%, 13.15%vs32.60%, respectively), with statistical significance (p<0.05). Conclusion Plasmakinetic enucleation of bladder tumors is safe and effective in the treatment of bladder neoplasms.